Autologous stem cell transplantation in progressive multiple sclerosis - An interim analysis of efficacy

Journal of Clinical Immunology

Volumn 20, Issue 1, 2000, Pages 24-30

  Fassas, A ^a   Anagnostopoulos, A ^a   Kazis, A ^b   Kapinas, K ^b   Sakellari, L ^a   Kimiskidis, V ^b   Smias, C ^a   Eleftheriadis, N ^a   Tsimourtou, V ^b  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Autoimmune disease; Multiple sclerosis; Stem cell transplantation

Indexed keywords

BETA INTERFERON; CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CLINICAL ARTICLE; FEMALE; GRAFT INFECTION; HASHIMOTO DISEASE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROTOXICITY; PRIORITY JOURNAL; RELAPSE; STEM CELL TRANSPLANTATION; SURVIVAL; TREATMENT OUTCOME;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0034093120     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006686426090     Document Type: Article

References (25)

1. 1. Gulcher JR, Vartanian T, Stefansson K: Is multiple sclerosis an autoimmune disease? Clin Neurosci 2:246-252, 1994
2. 2. Hohlfeld R, Londi M, Massacesi L, Salvetti M: T-cell immunity in multiple sclerosis. Immunol Today 16:259-261, 1995
3. 3. Snowden JA, Brooks PM, Biggs JC: Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol 99:9-22, 1997
4. 4. Matthews WB: Course and prognosis. In McAlpine's Multiple Sclerosis, WB Matthews, A Compston, IV Allen, CN Martyn (eds). Singapore, Churchill Livingstone, 1991, pp. 139-163
5. 5. Rudick RA, Cohen JA, Weinstock-Guttman B, Kinkel RP, Ransohoff RM: Management of multiple sclerosis. New Engl J Med 337:1604-1611, 1997
6. 6. Marmont AM, van Bekkum DW: Stem cell transplantation for severe autoimmune diseases. Bone Marrow Transplant 16:497-498, 1995
7. 7. Marmont AM: Stem cell transplantation for severe autoimmune diseases: Progress and problems. Haematologica 83:733-743, 1998
8. 8. van Bekkum DW, Marmont AM, Tyndall A, Vriesendorp FJ, Apatoff BJ, Rowlings PA: Severe autoimmune diseases: A new target for bone marrow transplantation. Stem cells 14:460-472, 1996
9. 9. McAllister LD, Beatty PG, Rose J: Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 19:395-397, 1997
10. 10. Apatoff BR: Stem cell transplantation in the treatment of multiple sclerosis. Stem Cells 14:467-472, 1996
11. 11. van Gelder M, van Bekkum DW: Effective treatment of relapsing experimental autoimmune encephatomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant 18: 1029-1034, 1996
12. 12. van Bekkum DW: New opportunities for the treatment of severe autoimmune diseases: Bone marrow transplantation. Clin Immunol Immunopathol 89:1-10, 1998
13. 13. Karussis DM, Vourka-Karussis U, Lehmann D, Ovadia H, Mizrachi-Koll R, Ben-Nun A, Abramsky O, Slavin S: Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J Clin Invest 92:765-772, 1993
14. 14. Fassas A, Anagnostopoulos A, Kazis A, Kapinas A, Sakellari I, Kimiskidis V, Tsompanakou A: Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: First results of a pilot study. Bone Marrow Transplant 20:631-638, 1997
15. 15. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, Yannaki E: Autologous blood stem cell therapy for progressive multiple sclerosis. In Autologous Blood and Marrow Transplantation - Proceedings of the Ninth International Symposium, Arlington, Texas, KA Dicke, A Keating (eds). Charlottesville, Carden Jennings, 1999, pp 452-463
16. 16. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33:1444-1452, 1983
17. 17. Tyndall A, Gratwohl A: Blood and marrow stem cell transplants in autoimmune disease: A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow transplantation (EBMT). Bone Marrow Transplant 19:643-645, 1997
18. 18. Comi G, Kappos L, Clanet M, Ebers G, Fassas A, Fazekas F, Filippi M, Hartung HP, Martino G, Tyndall A, van der Meche FGA, BMT-MS Study Group: guidelines for blood and marrow stem cell transplantation in multiple sclerosis. J Neurology (in press)
19. 19. Weinshenker G, Issa M, Baskerville J: Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology 46:1613-1619, 1996
20. 20. European Study Group on Interferon β-1b in Secondary Progressive MS: Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis. Lancet 352:1491-1497, 1998
21. 21. Slavin S, Karussis D, Weiss L, Vourka-Karoussis U, Abramsky O: Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders. Transplant Proc 25:1274-1275, 1993
22. 22. Snowden JA, Brooks PM: Hematopoietic stem cell transplantation in rheumatic diseases. Current Opinion Rheumatol 11:167-172, 1999
23. 23. Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, Terry C, Lobeck L, Russel EJ, Goolsby C, Rosen S, Gordon LI, Keever-Taylor C, Brush M, Fishman M, Burns WH: T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 21:537-541, 1998
24. 24. Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, Lobeck L, Goolsby C, Rowlings P, Davis FA, Stefoski D, Terry C, Keever-Taylor C, Rosen S, Vesole D, Fishman M, Brush M, Mujias S, Villa M, Burns WH: Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 92:3505-3514, 1998
25. 25. Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, Dang CV, Brodsky T, Jones RJ: Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 129:1031-1035, 1998